Volker Pfahlert (Roche Diagnostics (Group Division))

Pfahlert, Volker (LipoFIT GmbH 201001– Managing Director COO before Roche Diagnostics + Dräger Medical)

	Organisation	Roche Diagnostics (Group Division)
	Group	Roche (Group)
	Product	NMR spectroscopy
	Product 2	analytical services

Record changed: 2022-04-24

Picture EBD Group BIO-Europe 2025 Wien Vienna to 17 Oct 650x200px

More documents for Volker Pfahlert

[1] Numares AG. (3/24/21). "Press Release: Numares Announces FDA 510(k) Submission of Axinon System, a NMR Platform for Metabolomics-based, AI-driven Diagnostics". Boston, MA & Regensburg....
[2] Numares AG. (1/21/21). "Press Release: Numares and Bruker Sign Agreement to Enable Advanced Metabolomics-based Clinical Diagnostics". Boston, MA & Regensburg....
[3] Numares AG. (6/8/20). "Press Release: Numares Announces Winton Gibbons as New President of US Subsidiary". Regensburg....
[4] Numares AG. (9/10/19). "Press Release: Numares Elects Kathy L. Bates as New Member of the Supervisory Board". Regensburg....
[5] Numares AG. (2/5/19). "Press Release: Numares and Mayo Clinic Laboratories Announce Collaboration to Develop New Diagnostic Tests Using Distinctive Nuclear Magnetic Resonance Technology". Regensburg & Rochester, MN....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com